Loading insider details...
Beta
Latest Form 4 (Jul 17, 2026): Grant/Award of 25,000 GANX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 17, 2026 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 25,000 | n/a |
| Apr 24, 2026 | BioAge Labs, Inc. (BIOA) | Exercise/Conversion | 3,542 | $15.5K |
| Mar 3, 2026 | BioAge Labs, Inc. (BIOA) | Exercise/Conversion | 3,542 | $15.5K |
| Feb 19, 2026 | BioAge Labs, Inc. (BIOA) | Grant/Award | 110,000 | n/a |
| Feb 3, 2026 | BioAge Labs, Inc. (BIOA) | Exercise/Conversion | 3,541 | $15.5K |
| Jan 21, 2026 | BioAge Labs, Inc. (BIOA) | Exercise/Conversion | 3,542 | $15.5K |
| Jan 15, 2026 | BioAge Labs, Inc. (BIOA) | Exercise/Conversion | 27,000 | $226.5K |
| Jan 7, 2026 | Coya Therapeutics, Inc. (COYA) | Grant/Award | 10,000 | n/a |
| Aug 19, 2025 | Coya Therapeutics, Inc. (COYA) | Exercise/Conversion | 17,557 | $19.1K |
| Jun 25, 2025 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 15,000 | n/a |